Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_assertion type Assertion NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_head.
- NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_assertion wasGeneratedBy ECO_0000203 NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_provenance.
- NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_assertion wasDerivedFrom befree-20140225 NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_provenance.
- NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_assertion SIO_000772 20668658 NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_provenance.
- NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_assertion evidence source_evidence_literature NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_provenance.
- NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_assertion description "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256362.RAGq5P0Fgu1UnqFLfKFAhnz6fEgNQdAeXeSV1KkkriJHM130_provenance.